Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03058185Recruiting

Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)

Showing all 1 trials

Research Network

Active Sponsors

  • Institut National de la Santé Et de la Recherche Médicale, France1
  • Pitié-Salpêtrière Hospital1
  • Institut de Myologie, France1
  • Assistance Publique - Hôpitaux de Paris1

Top Investigators

Related Conditions

  • Laminopathies1

Activity Timeline